The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.
We have previously described a 14,700 m.w. protein (14.7K) encoded by the E3 region of adenovirus that prevents TNF-mediated cytolysis of adenovirus-infected C3HA mouse fibroblasts. In the studies described here we have extended our analysis of TNF cytolysis of C3HA cells and the circumstances under which 14.7K protects these cells from cytolysis. C3HA cells were killed by TNF in the presence of inhibitors of protein synthesis, in the presence of cytochalasin E (which disrupts the microfilaments), and when adenovirus E1A was expressed. As described for other cell types, pretreatment of C3HA cells with TNF prevented cytolysis by TNF plus cycloheximide or TNF plus cytochalasin E, indicating that TNF induces a response that protects against these treatments. Remarkably, when 14.7K was expressed in virus-infected cells, it also prevented TNF-induced lysis whether sensitivity to TNF was induced by inhibition of protein synthesis, disruption of the cytoskeleton by cytochalasin E, or expression of adenovirus E1A. The 14.7K protein also prevented TNF lysis of cells that are spontaneously sensitive to TNF lysis. Thus, 14.7K appears to be a general inhibitor of TNF cytolysis, and as such should be an important tool in unraveling the mechanism of TNF cytolysis. There was one exception; NCTC-929 cells were spontaneously sensitive to TNF lysis and that lysis was not affected by 14.7K even though the protein was made in large quantities and was metabolically stable in these cells. This suggests that there is heterogeneity among TNF-sensitive cell lines. The 14.7K protein was found in both the nuclear and cytosol fractions of TNF resistant as well as all spontaneously sensitive cells suggesting that 14.7K may have more than one site of action within the cell.
Gooding
L R
LR
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322.
Sofola
I O
IO
Tollefson
A E
AE
Duerksen-Hughes
P
P
Wold
W S
WS
D008841:Actin Cytoskeleton / Q000187:drug effects; D017456:Adenovirus Early Proteins; D000260:Adenoviruses, Human / Q000276:immunology*; D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects*; D003513:Cycloheximide / Q000494:pharmacology; D003572:Cytochalasins / Q000494:pharmacology; D066298:In Vitro Techniques; D051379:Mice; D008970:Molecular Weight; D009856:Oncogene Proteins, Viral / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D017456:Adenovirus Early Proteins; D003572:Cytochalasins; D009856:Oncogene Proteins, Viral; D014409:Tumor Necrosis Factor-alpha; C007215:cytochalasin E; D003513:Cycloheximide